(1 - 11 from 12
)
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic...
news.abbvie.com
... widely recognized as the most challenging to treat genotype, with limited treatment options for newly diagnosed patients," said Edward Gane, ...
Achillion Presents Detailed Clinical Results on ACH and ACH
www.globenewswire.com
Lead Author: Edward Gane. As previously reported, 100% of patients achieved SVR12 after six- (n=12) or eight-weeks (n=12) of treatment in ...
Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating
www.globenewswire.com
- Achillion achieves 100% SVR12 in six-week regimen with combination of ACH and sofosbuvir for treatment-naïve genotype 1 HCV Achillion...
Mavyret safe, effective for HCV with chronic kidney disease
www.healio.com
Treatment with Mavyret for 12 weeks resulted in high rates of sustained virologic response among patients with hepatitis C and stage 4 or 5 chronic kidney...
sorted by relevance / date